Nasdaq:
ANIX
Home
About
Overview
Management Team
Board of Directors
Scientific Advisors
Breast Cancer Clinical Advisory Board
Cancer Business Advisory Board
Technologies
CAR-T
Introduction
Markets
Science
Collaborators
Cancer Vaccines
Introduction
Markets
Science
Collaborators
Breast Cancer Clinical Advisory Board
Pipeline
Investors
Overview
News Releases
Events & Presentations
Events
Corporate Presentation
Stock Information
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
SEC Filings
Financial Reports
Annual Reports
Quarterly Reports
Corporate Governance
Governance Documents
Committee Charters
News
Press Releases
Anixa In The News
Publications
YouTube Channel
Contact Us
SEC Filings
Investors
Investors
Overview
News Releases
Events & Presentations
Events
Corporate Presentation
Stock Info
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Financial Reports
Annual Reports
Quarterly Reports
Governance
Governance Documents
Committee Charters
Investor Resources
Investor FAQs
Email Alerts
Fact Sheet
Contact IR
RSS News Feed
SEC Filings
Overview
Filter Filings:
View All
10-C
10-K
10-K/A
10-K405
10-K405/A
10-Q
10-Q/A
144
3
3/A
4
4/A
424B2
424B3
424B5
5
8-A12B
8-K
ARS
AW
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DEL AM
DFAN14A
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PREC14A
PRER14A
RW
S-1
S-1/A
S-3
S-3/A
S-8
S-8 POS
SC 13D
SC 13D/A
SC 13G
SC 13G/A
UPLOAD
Date
Form
Description
Docs
XBRL
Pages
03/05/18
8-K
Current report filing
Related Documents
EX-99.1
4
02/15/18
CT ORDER
Confidential treatment order
1
02/15/18
SC 13D
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities
6
02/14/18
S-8
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Related Documents
EX-5.1
EX-1
37
02/12/18
DEF 14A
Definitive proxy statements
36
01/30/18
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
14
01/30/18
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
14
01/26/18
PRE 14A
Preliminary proxy statement not related to a contested matter or merger/acquisition
36
01/23/18
8-K
Current report filing
3
01/09/18
10-K
Annual report pursuant to Section 13 and 15(d)
Related Documents
EX-10.14
EX-10.15
EX-21
EX-23.1
EX-31.1
EX-31.2
EX-32.1
EX-32.2
EX-99.3
148
<< Previous
1...
20
21
22
23
24
25
26
27
28
29
...92
Next >>
Sign up for email Updates
Be The First to Receive Breaking News
Sign Up Now